Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachael Pocock

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|November 5, 2020
PEACE in the midst of an emergency: a rash not to missChristiana Stavrou, Strachan Mackenzie, Rachael Pocock, et al.
British Journal of Haematology|May 4, 2021
Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemiaRachael Pocock, Nadine Farah, Simon E Richardson, et al.
Biomaterials|August 10, 2007
Biological applications of quantum dotsTimothy Jamieson, Raheleh Bakhshi, Daniela Petrova, et al.
British Journal of Haematology|July 4, 2023
Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccinationChristopher L Pinder, Dylan Jankovic, Thomas A Fox, et al.
Blood|May 4, 2022
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemiaPaul M Maciocia, Patrycja A Wawrzyniecka, Nicola C Maciocia, et al.
Cell Reports|May 16, 2025
Transcription factor cooperativity at a GATA3 tandem DNA sequence determines oncogenic enhancer-mediated activationJoana R Costa, Yang Li, Nurkaiyisah Zaal Anuar, et al.
Blood Advances|November 15, 2023
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experienceRohan Shotton, Rachel Broadbent, Alia Alchawaf, et al.
Blood|September 24, 2024
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemiaSunniyat Rahman, Gianna Bloye, Nadine Farah, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2020
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective StrategyAnthony R Mato, Lindsey E Roeker, Ryan Jacobs, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|November 5, 2020
PEACE in the midst of an emergency: a rash not to missChristiana Stavrou, Strachan Mackenzie, Rachael Pocock, et al.
British Journal of Haematology|May 4, 2021
Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemiaRachael Pocock, Nadine Farah, Simon E Richardson, et al.
Biomaterials|August 10, 2007
Biological applications of quantum dotsTimothy Jamieson, Raheleh Bakhshi, Daniela Petrova, et al.
British Journal of Haematology|July 4, 2023
Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccinationChristopher L Pinder, Dylan Jankovic, Thomas A Fox, et al.
Blood|May 4, 2022
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemiaPaul M Maciocia, Patrycja A Wawrzyniecka, Nicola C Maciocia, et al.
Cell Reports|May 16, 2025
Transcription factor cooperativity at a GATA3 tandem DNA sequence determines oncogenic enhancer-mediated activationJoana R Costa, Yang Li, Nurkaiyisah Zaal Anuar, et al.
Blood Advances|November 15, 2023
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experienceRohan Shotton, Rachel Broadbent, Alia Alchawaf, et al.
Blood|September 24, 2024
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemiaSunniyat Rahman, Gianna Bloye, Nadine Farah, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2020
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective StrategyAnthony R Mato, Lindsey E Roeker, Ryan Jacobs, et al.
Pageof 1